The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

8 Jul 2019 07:00

RNS Number : 7136E
Science Group PLC
08 July 2019
 

 

8 July 2019

Science Group plc

(the "Company")

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

Science Group plc (AIM:SAG) welcomes the Frontier announcement issued on Friday 5 July regarding the clarification of the Frontier statement issued on 14 June 2019. Science Group concludes that:

· Science Group's Offer is the only offer for Frontier - as announced on 1 July and posted to Frontier Shareholders on 2 July 2019;

· Contrary to previous indications by Frontier (14 June) regarding the alternative approach, it is now "unlikely that the discussions will result in an offer for" Frontier from this alternative source;

· Frontier's discussions regarding a further alternative new proposal from the same party are at no more than a "concept" stage, after 3 weeks of "urgently seeking to clarify" this alternative approach. The basic transaction framework has not even been agreed and "there is no meaningful prospect of agreeing Heads of Terms, less still entering into a definitive legal agreement, prior to the closing date of the Science Group Offer of 16 July 2019". This indicates that the "potential, but uncertain" discussions are preliminary and speculative; and

· Frontier's operating performance and expectations for the current year remain unchanged following the significant downgrade it announced on 9 May 2019, which resulted in Frontier's share price falling to a closing price of 13.4 pence.

 

In summary, despite the substantial premium being offered by Science Group relative to the share price on the date of the trading update, the Frontier Board are advising Frontier Shareholders to reject the Science Group Offer on the basis that at some undefined point in the future, Frontier may possibly agree a joint venture with an undefined party into which Frontier would transfer key assets. The structure and terms of this hypothetical activity are currently unknown to the Frontier Board and the potential value to be created and how any such value would be realised for Frontier Shareholders is completely unclear. Furthermore, even if this "potential, but uncertain, prospect" did develop, the Frontier Board may or may not grant Frontier Shareholders the opportunity to vote on this transfer of assets and the terms of any transaction.

 

Throughout the past 8 weeks, in the opinion of Science Group, Frontier has repeatedly taken actions which have had the effect of frustrating the proposed acquisition of Frontier by Science Group. This latest "concept" of a non-specific strategy being proposed by the Frontier Board can only be regarded similarly. It should be remembered that, at 31 December 2018, Frontier had net retained losses of $175.5 million resulting from Frontier's previous strategies and that between January 2018 and 9 May 2019, the current Frontier Board pursued a strategy that resulted in a share price decline of over 90%.

 

At the close of trading on 5 July 2019, Science Group held 11,879,601 shares, equivalent to 29.2% of the voting share capital of Frontier. Science Group reiterates its previous statements that it does not anticipate supporting any alternative "potential corporate transaction".

 

Science Group does not anticipate increasing the Offer price and reminds Frontier Shareholders that the Offer of 35 pence per share, represents:

· a 161.6% premium to the closing share price on 9 May 2019, the date of the Frontier trading update; and

· a 137.3% premium to the share price on 17 May 2019, the last trading day prior to the announcement of Science Group's approach.

 

Science Group also reminds Frontier Shareholders that the closing date for the Science Group Offer is Tuesday 16 July 2019. At the present time, and taking into account the Frontier announcement issued on 5 July, Science Group does not anticipate extending the Offer, nor the Panmure Gordon Trading Facility, but retains the option to do so if considered appropriate at the sole discretion of the Science Group Board

 

In conclusion, Science Group encourages Frontier Shareholders to accept the Science Group Offer, or sell their shares through the Panmure Gordon Trading Facility, as soon as possible and in any event prior to the closing date of Tuesday 16 July 2019.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina

(Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

MHP Communications (PR Adviser to Science Group)

Reg Hoare / Pete Lambie

 

Tel: +44 (0) 20 3128 8100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBRGDRSGGBGCR
Date   Source Headline
25th Sep 20177:00 amRNSChange of Adviser
21st Sep 20175:25 pmRNSNotification of Major Interest in Shares
8th Sep 20177:00 amRNSNotice of Results
1st Aug 20172:55 pmRNSTotal Voting Rights
27th Jul 20177:00 amRNSHalf Year Trading Update
30th Jun 20177:00 amRNSTotal Voting Rights
28th Jun 20174:41 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Jun 20174:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Jun 20172:45 pmRNSTotal Voting Rights
11th May 20173:30 pmRNSTR1: Notification of Major Interest in Shares
9th May 20179:48 amRNSResult of AGM
9th May 20177:00 amRNSNotification re discontinued business
5th May 20177:00 amRNSTrading update
10th Apr 20177:00 amRNSFrontier Silicon launches miniaturised DAB+ module
5th Apr 20177:00 amRNSBlock listing Interim Review
4th Apr 20173:10 pmRNSPosting of Annual Report and Notice of AGM
3rd Apr 20177:00 amRNSDesign win for Zound Industries 'Urban Ears'
24th Mar 20177:00 amRNSFinal Results
17th Mar 20175:10 pmRNSChange in ISIN
15th Mar 20177:00 amRNSMultiple design wins
3rd Mar 20177:00 amRNSNotice of Preliminary Results
7th Feb 20177:00 amRNSDirector Dealings and Grant of Options
26th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSAppointment of Non-Executive Director
25th Nov 201612:55 pmRNSTotal Voting Rights
1st Nov 20169:30 amRNSResult of EGM
7th Oct 20167:30 amRNSPosting of Circular & Notice of EGM
27th Sep 20167:00 amRNSInterim Results
14th Sep 20167:00 amRNSNotice of Results
13th Sep 20161:45 pmRNSTotal Voting Rights
2nd Sep 20167:00 amRNSDesign Win with World's Largest Speaker Company
29th Jul 20163:10 pmRNSDirectorate Change
22nd Jul 20167:00 amRNSSale of Healthcare division and trading update
26th May 201611:00 amRNSTotal Voting Rights
17th May 201610:38 amRNSResult of AGM
31st Mar 20161:01 pmRNSTotal Voting Rights
22nd Mar 20167:00 amRNSFull year results
18th Mar 20161:07 pmRNSBlock Listing Update
7th Mar 201612:01 pmRNSNotice of Results
29th Feb 20163:17 pmRNSTotal Voting Rights
25th Feb 20163:11 pmRNSHolding(s) in Company
22nd Feb 20164:07 pmRNSHolding(s) in Company
19th Feb 20163:51 pmRNSImagination Technologies Group plc stake
8th Feb 20164:11 pmRNSDirectorate Change
21st Jan 20167:00 amRNSYear-end trading update
20th Oct 20157:00 amRNSNew £5m banking facility
1st Oct 20157:00 amRNSFrontier Silicon powers ROBERTS R-Line audio range
30th Sep 20158:00 amRNSAmendment to terms of Director's share options
29th Sep 20157:00 amRNSHalf year results
24th Sep 20151:04 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.